Table 2.

Association of CD44 expression with the clinicopathological characteristics from TCGA data.

Factors	Total (N)	OR with 95% CI	P
Age (≥69 vs. <69 years)	406	0.94 (0.64–1.39)	0.766
Gender (Male vs. female)	406	1.08 (0.69–1.68)	0.735
Grade (High vs. low)	403	1.01 (0.41–2.47)	0.991
T stage (T3-4 vs. T1-2)	373	1.01 (0.65–1.55)	0.978
Lymph node metastasis (Positive vs. negative)	364	0.86 (0.56–1.32)	0.495
Metastasis (Positive vs. negative)	206	0.65 (0.19–2.3)	0.508

N: number of the study population; OR: odds ratio; 95% CI: 95% confidence interval; TCGA: The Cancer Genome Atlas.